SG10202112135VA - Purification of rapamycin derivatives - Google Patents
Purification of rapamycin derivativesInfo
- Publication number
- SG10202112135VA SG10202112135VA SG10202112135VA SG10202112135VA SG10202112135VA SG 10202112135V A SG10202112135V A SG 10202112135VA SG 10202112135V A SG10202112135V A SG 10202112135VA SG 10202112135V A SG10202112135V A SG 10202112135VA SG 10202112135V A SG10202112135V A SG 10202112135VA
- Authority
- SG
- Singapore
- Prior art keywords
- purification
- rapamycin derivatives
- rapamycin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361799857P | 2013-03-15 | 2013-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202112135VA true SG10202112135VA (en) | 2021-12-30 |
Family
ID=51538094
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201707632PA SG10201707632PA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
| SG11201507406YA SG11201507406YA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
| SG10202112135VA SG10202112135VA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201707632PA SG10201707632PA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
| SG11201507406YA SG11201507406YA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US9598439B2 (en) |
| EP (1) | EP2972258B1 (en) |
| JP (4) | JP2016519086A (en) |
| CN (2) | CN108864149B (en) |
| CA (1) | CA2901162C (en) |
| ES (1) | ES2897473T3 (en) |
| HK (1) | HK1218959A1 (en) |
| SG (3) | SG10201707632PA (en) |
| WO (1) | WO2014145780A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2934401C (en) | 2009-11-02 | 2017-01-10 | Pulse Therapeutics, Inc. | Magnetomotive stator system and methods for wireless control of magnetic rotors |
| ES2897473T3 (en) | 2013-03-15 | 2022-03-01 | Biosensors Int Group Ltd | Purification of rapamycin derivatives |
| CN109851626B (en) * | 2019-01-08 | 2021-11-02 | 扬子江药业集团四川海蓉药业有限公司 | Method for separating and purifying temsirolimus |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9713730D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
| US20060198867A1 (en) * | 1997-09-25 | 2006-09-07 | Abbott Laboratories, Inc. | Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy |
| US7452692B2 (en) | 2002-02-13 | 2008-11-18 | Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Method for extracting a macrolide from biomatter |
| TR200500302T3 (en) * | 2003-03-31 | 2005-04-21 | Biogal Gyogyszergyar Rt. | Crystallization and purification of macrolides. |
| US7220755B2 (en) * | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| CA2548297C (en) * | 2003-12-05 | 2011-06-14 | Biocon Limited | Process for the purification of macrolides |
| JP4716280B2 (en) * | 2004-03-01 | 2011-07-06 | テルモ株式会社 | Process for producing O-alkylated rapamycin derivatives |
| BRPI0509852A (en) * | 2004-04-14 | 2007-10-23 | Wyeth Corp | method for the regiospecifically preparation of rapamycin 42-ester derivatives, regiospecifically preparation of rapamycin 42-ester, composition, product, and, pharmaceutical kit |
| WO2006060615A1 (en) | 2004-12-01 | 2006-06-08 | Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg | Non-hygroscopic and powdery amorphous pimecrolimus |
| AU2006218918A1 (en) * | 2005-03-02 | 2006-09-08 | Wyeth | Purification of rapamycin |
| US20060222627A1 (en) * | 2005-03-30 | 2006-10-05 | Andrew Carter | Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue |
| KR20080077147A (en) * | 2005-12-07 | 2008-08-21 | 와이어쓰 | Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry |
| US7700614B2 (en) * | 2005-12-14 | 2010-04-20 | Abbott Laboratories | One pot synthesis of tetrazole derivatives of rapamycin |
| GB0601406D0 (en) * | 2006-01-24 | 2006-03-08 | Novartis Ag | Organic Compounds |
| AU2007223963A1 (en) | 2006-03-07 | 2007-09-13 | Wyeth | Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants |
| US7812032B2 (en) * | 2006-07-25 | 2010-10-12 | Abbott Laboratories | Crystalline forms of rapamycin analogs |
| US7820812B2 (en) * | 2006-07-25 | 2010-10-26 | Abbott Laboratories | Methods of manufacturing crystalline forms of rapamycin analogs |
| JP2010509317A (en) * | 2006-11-10 | 2010-03-25 | バイオコン リミテッド | Pure form of rapamycin and method of recovery and purification |
| EP2090580B1 (en) | 2006-11-27 | 2014-06-04 | Terumo Kabushiki Kaisha | Process for producing o-alkylated rapamycin derivative, and o-alkylated rapamycin derivative |
| US20080287675A1 (en) * | 2007-05-18 | 2008-11-20 | Abbott Laboratories | Cascade system |
| CN101077334A (en) * | 2007-06-29 | 2007-11-28 | 济南康泉医药科技有限公司 | Anticancer composition containing tyrosine kinase inhibitor |
| TW200948361A (en) * | 2008-05-26 | 2009-12-01 | Chunghwa Chemical Synthesis & Biotech Co Ltd | Method for synthesizing Biolimus A9 and the like and method for improving stability of the same |
| US20100055145A1 (en) * | 2008-08-29 | 2010-03-04 | Biosensors International Group | Stent coatings for reducing late stent thrombosis |
| EP2421571A2 (en) | 2009-04-24 | 2012-02-29 | Boston Scientific Scimed, Inc. | Use of drug polymorphs to achieve controlled drug delivery from a coated medical device |
| CN102464669B (en) * | 2010-11-17 | 2014-04-16 | 浙江海正药业股份有限公司 | Amorphous everolimus and preparation method thereof |
| WO2013022458A1 (en) | 2011-08-05 | 2013-02-14 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
| US9056152B2 (en) * | 2011-08-25 | 2015-06-16 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
| CN102786534A (en) * | 2012-05-25 | 2012-11-21 | 上海现代制药股份有限公司 | Preparation method of everolimus |
| ES2897473T3 (en) | 2013-03-15 | 2022-03-01 | Biosensors Int Group Ltd | Purification of rapamycin derivatives |
-
2014
- 2014-03-17 ES ES14763326T patent/ES2897473T3/en active Active
- 2014-03-17 CN CN201811056060.XA patent/CN108864149B/en active Active
- 2014-03-17 SG SG10201707632PA patent/SG10201707632PA/en unknown
- 2014-03-17 CN CN201480013252.6A patent/CN105102967B/en active Active
- 2014-03-17 SG SG11201507406YA patent/SG11201507406YA/en unknown
- 2014-03-17 WO PCT/US2014/030602 patent/WO2014145780A1/en active Application Filing
- 2014-03-17 SG SG10202112135VA patent/SG10202112135VA/en unknown
- 2014-03-17 JP JP2016503426A patent/JP2016519086A/en not_active Withdrawn
- 2014-03-17 CA CA2901162A patent/CA2901162C/en active Active
- 2014-03-17 EP EP14763326.7A patent/EP2972258B1/en active Active
-
2015
- 2015-09-14 US US14/853,711 patent/US9598439B2/en active Active
-
2016
- 2016-06-17 HK HK16107001.4A patent/HK1218959A1/en unknown
-
2017
- 2017-02-02 US US15/422,593 patent/US10202402B2/en active Active
-
2018
- 2018-12-18 US US16/224,140 patent/US10597406B2/en active Active
-
2019
- 2019-03-07 JP JP2019041615A patent/JP2019089848A/en active Pending
-
2020
- 2020-03-02 US US16/806,770 patent/US11046711B2/en active Active
-
2021
- 2021-05-06 JP JP2021078418A patent/JP2021121601A/en active Pending
- 2021-06-28 US US17/360,973 patent/US11780850B2/en active Active
-
2023
- 2023-08-25 JP JP2023136964A patent/JP2023164476A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2972258A1 (en) | 2016-01-20 |
| CN108864149B (en) | 2022-04-05 |
| US11780850B2 (en) | 2023-10-10 |
| ES2897473T3 (en) | 2022-03-01 |
| SG11201507406YA (en) | 2015-10-29 |
| HK1218959A1 (en) | 2017-03-17 |
| CA2901162A1 (en) | 2014-09-18 |
| EP2972258A4 (en) | 2016-12-21 |
| US20190256527A1 (en) | 2019-08-22 |
| WO2014145780A1 (en) | 2014-09-18 |
| JP2019089848A (en) | 2019-06-13 |
| US20170334928A1 (en) | 2017-11-23 |
| SG10201707632PA (en) | 2017-11-29 |
| WO2014145780A4 (en) | 2014-11-20 |
| JP2023164476A (en) | 2023-11-10 |
| CN105102967A (en) | 2015-11-25 |
| US20160002262A1 (en) | 2016-01-07 |
| US10202402B2 (en) | 2019-02-12 |
| US9598439B2 (en) | 2017-03-21 |
| JP2016519086A (en) | 2016-06-30 |
| US11046711B2 (en) | 2021-06-29 |
| CN105102967B (en) | 2018-10-12 |
| CN108864149A (en) | 2018-11-23 |
| CA2901162C (en) | 2021-06-01 |
| US10597406B2 (en) | 2020-03-24 |
| JP2021121601A (en) | 2021-08-26 |
| US20220024947A1 (en) | 2022-01-27 |
| US20200270272A1 (en) | 2020-08-27 |
| EP2972258B1 (en) | 2021-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1221466A1 (en) | Bipyrazole derivatives as jak inhibitors jak | |
| PL2803401T3 (en) | Purification of air | |
| HK1216429A1 (en) | Methods for purification of rylsulfatase | |
| HRP20181710T1 (en) | Use of benzimidazole-proline derivatives | |
| AR092198A1 (en) | DERIVATIVES OF PIRAZOLOPIRIMIDINAS | |
| ZA201602198B (en) | Preparation of hydroxy-benzylbenzene derivatives | |
| EP2948557A4 (en) | Purification of cadaverine | |
| ZA201602831B (en) | Use of lactones | |
| HK1218959A1 (en) | Purification of rapamycin derivatives | |
| HK1218118A1 (en) | Low temperature synthesis of rapamycin derivatives | |
| GB201314581D0 (en) | Purification |